4 research outputs found
RBCV<sub>2</sub> and RBCV<sub>2</sub> increment in HD women according to <i>ESR1 PvuII</i> and <i>Xbal</i> genotypes.
<p>Data are presented as Whiskers plot. Comparison between groups was made by Mann Whitney test. RBCV<sub>2</sub>: Red blood cells velocity (mm/s) after estrogen administration. RBCV<sub>2</sub> increment: Red blood cells velocity increment (%) after 1 min ischemia and subsequent reactive hyperemia response upon occlusion release after estrogen administration. A and C, RBCV<sub>2</sub> and <i>PvuII</i> and <i>Xbal</i> genotypes, respectively. B and D, RBCV<sub>2</sub> increment and <i>PvuII</i> and <i>Xbal</i> genotypes, respectively.</p
Frequencies of <i>ESR1</i> and <i>NOS3</i> polymorphisms in HD and healthy women.
<p>Comparison between genotypes was performed by Fisher’s exact test.</p
RBCV<sub>1</sub> and RBCV<sub>1</sub> increment in HD women according to <i>NOS3 T-786C and G894T</i> genotypes.
<p>Data are presented as Whiskers plot. Comparison between groups was made by Mann Whitney test. RBCV<sub>1</sub>: Red blood cells velocity (mm/s). RBCV<sub>1</sub> increment: Red blood cells velocity increment (%) after 1 min ischemia and subsequent reactive hyperemia response upon occlusion release. A, C, and E, RBCV<sub>1</sub> and <i>VNTR</i>, <i>-786C</i>, and <i>G894T</i> genotypes, respectively. B, D, and F, RBCV<sub>1</sub> increment and <i>VNTR</i>, <b><i>-</i></b><i>786C</i>, and <i>G894T</i> genotypes, respectively.</p
Clinical and laboratory data in HD and healthy women.
<p>Reference values: HOMA-IR, 2.1 T 0.7; Triglycerides, <150 mg/dl; HDL cholesterol, >50 mg/dl; hS C-reactive protein, <0.3 mg/dl; Estradiol, <44 pg/ml (post menopause without HT);</p><p>Oxidized LDL, <0.5 nmol/mg ApoPt.</p><p>BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; RBCV<sub>1</sub>: red blood cell velocity before estradiol: RBCV<sub>max1</sub>: peak red blood cell velocity before estradiol: RBCV<sub>1</sub> increment: % of RBCV<sub>max1</sub> increase in relation to RBCV<sub>1</sub>; TRBCV<sub>max1</sub>: time to reach peak red blood cell velocity before estradiol; RBCV<sub>2</sub>: red blood cell velocity after estradiol: RBCV<sub>max2</sub>: peak red blood cell velocity after estradiol: RBCV<sub>2</sub> increment: % of RBCV<sub>max2</sub> increase in relation to RBCV<sub>2</sub>: TRBCV<sub>max2</sub>: time to reach peak red blood cell velocity after estradiol. Comparison between groups was performed by Mann Whitney test.</p